IL-1 and TNF-are proinflammatory cytokines that affect inflammatory responses and matrix degradation. Although interleukin-1 (IL-1 )and tumor necrosis factor-(TNF-) have been detected in the synovial fluids from patients such as temporomandibular joint disorders(TMD), there is little known about the molecular mechanisms of inflammatory conditions of TMD. To identify putative factors associated with temporomandibular joint (TMJ) inflammation, we investigated IL-1 and/or TNF--responsive genes of synovial fibroblasts from patients with TMD using microarray analysis. Granulocyte macrophage colony stimulating factor(GM-CSF)was one of the genes whose expression was strongly up-regulated in synovial fibroblasts by IL-1 and/or TNF-. The gene expressions of macrophage colony stimulating factor(M-CSF)and Granulocyte colony stimulating factor (G-CSF) were also up-regulated by IL-1 and/or TNF-. Gene expression and protein production of GM-CSF and G-CSF, but not of M-CSF, were synergistically increased in synovial fibroblasts stimulated with IL-1 and TNF-. M-CSF protein was only detected in the conditioned medium of the non-stimulated control in which GM-CSF and G-CSF were not detected. In addition, MAPK and NF B inhibitors inhibited IL-1 and TNF-stimulated production of GM-CSF and M-CSF. CSFs act on hemopoietic cells as growth factors and activation/differentiation factors. These results suggest that expression of CSFs in synovial fibroblasts stimulated by IL-1 and/or TNF-is one factor associated with inflammatory progression of the intracapsular pathological conditions of the TMJ.
Introduction
The temporomandibular joint (TMJ) is the articulation that is formed between the mandibular condyle and the temporal bone, and it plays an important role in functions such as the jaw motion that is involved in speaking, chewing, and swallowing. Temporomandibular joint disorders (TMD), which are defined as a subgroup of craniofacial pain problems that involve the TMJ, masticatory muscles and associated head and neck musculoskeletal structures, are characterized by limited mandibular motion, joint noise, and arthralgia. The recent insights obtained from arthroscopic (1, 2) and magnetic resonance imaging findings(3), histological studies (4) and synovial fluid analysis (5)may contribute to understanding the intracapsular pathologic conditions of the TMJ, such as internal derangement(ID), disc displacement(DD), fibrous adhesions, synovial inflammation(synovitis)and osteoarthritis(OA). These entities are not mutually exclusive and may coexist (1) (2) (3) (4) (5) .
Synovitis, an inflammatory disorder of the synovial membrane, frequently accompanies ID and/or OA in the TMJ (6) and has been suggested to be a key feature of intracapsular pathological conditions of the TMJ (7) . The synovial membrane lines all of the intra-articular structures, Correspondence to : Suguru Watanabe E-mail : gakuge.suguru.watanabe@gmail.com except for the articular cartilage of the eminence, fossa and mandibular condyle, and the articular disc (3) . The lining layer of synovial tissue is composed of fibroblast-like and macrophage-like cells and overlies loose connective tissue of the synovial sublining that contains blood vessel sublining fibroblasts and leukocytes. Synovial fibroblasts that are producing a number of putative mediators of inflammation and tissue degradation (4, 5, 8) and other immune cells communicate with one another in a unique inflammatory microenvironment (4) . An understanding of the molecular mechanisms that underlie the activities of these factors may contribute to an understanding of the pathogenesis of TMD; however, little is known about the molecular mechanisms that underlie the development of the pathological condition in the TMJ(9).
Interleukin-1 (IL-1 ) and tumor necrosis factor-(TNF-)are proinflammatory cytokines that affect cell proliferation, inflammatory responses and matrix remodeling (10, 11) . Elevated expression of IL-1 and TNF-in the joint is known to result in activation of inflammatory and degradative pathways in synovial cells, which in turn contribute to the progression of rheumatoid arthritis(RA) (11, 12) . In previous studies, levels of IL-1 and TNF-were also found to be elevated in synovial fluid obtained from TMD patients with OA and ID (5, 13) . Our previous study demonstrated that IL-1 or TNF-induced the gene expression and protein production of many inflammatory mediators such as chemokines and cytokines in synovial fibroblasts from patients with OA and/or ID of the TMJ (14) .
Here, we performed an oligonucleotide microarray analysis of human synovial fibroblasts treated with IL-1 and/or TNF-. The genes encoding granulocyte macrophage colony stimulating factor(GM-CSF)and macrophage colony stimulating factor(M-CSF)were found to be highly upregulated in IL-1 and/or TNF--treated synovial fibroblasts. The colony-stimulating factor(CSF)family includes CSF-1/M-CSF, CSF-2/GM-CSF, and CSF-3/ granulocyte colony-stimulating factor (G-CSF). CSFs were originally defined in vitro as hemopoietic growth factors(15), but have since been shown to act on mature myeloid populations as pro-survival and/or activation/differentiation factors (16) .
Additionally, CSFs are also reported to have many proinflammatory functions and function as key factors in inflammatory conditions of joints such as RA (17) (18) (19) . We also investigated the effects of stimulation of proinflammatory cytokines such as IL-1 and/or TNF-on the gene expression and production of CSFs in synovial fibroblasts from TMJ patients. Human synovial fibroblasts were isolated from the synovial tissues of these patients using the out-growth method of Ogura et al (20) . The culture medium used was Table 2 lists the primer sequences used for this analysis. Analyzed genes were examined for their relative expression to their respective control by using the C T method (22) . All analyses were performed in three replicates. The results were confirmed by three independent experiments.
Materials and Methods

Cell
Enzyme-linked immunosorbent assay (ELISA)
Synovial fibroblasts were plated in 24-well plates(5×10 
Results
Gene expression profiling
Of the 8133 genes on the DNA microarray, 5737 genes were upregulated with IL-1 , TNF-, and co-stimulation with IL-1 +TNF-but there was less overlap in the downregulated genes (Fig. 1) . Table 3 increased over the first 4 h, it then decreased over the next 4 h (Fig. 2 (b) ). 
CSF protein production
We first examined the time course of CSF protein levels in the conditioned media from synovial fibroblasts treated with IL-1 , TNF-, or IL-1 +TNF-co-stimulation. GM-CSF and G-CSF protein levels were increased by all treatments in a time dependent manner (Fig. 3(a)and(c) ). G-CSF production was strongly increased at the later culture times (Fig. 3   (c) ). The highest increases in GM-CSF and G-CSF protein levels were seen with IL-1 +TNF-co-stimulation, followed by IL-1 , and then TNF-. In contrast, the M-CSF protein level was similar for all treatments, and the level plateaued from 8 to 48 h during treatment with IL-1 and IL-1 +TNF-co-stimulation (Fig. 3 (b) ). For all CSFs, the patterns of protein production appeared to reflect the patterns of gene expression.
We next examined CSF protein production in response to various IL-1 and TNF-doses. Synovial fibroblasts were incubated with concentrations of IL-1 ranging from 0.01 to 1 ng/ml, or TNF-ranging from 1 to 100 ng/ml for 24 h. CSF protein production occurred in an IL-1 or TNF--concentration dependent manner (Fig. 4) . GM-CSF and G-CSF protein production was higher with IL-1 -than with TNF--stimulation. M-CSF was the only CSF that was detected at the protein level in the conditioned medium of the non-stimulated control (Fig. 4(c)and(d) ). GM-CSF and G-CSF protein levels in this conditioned medium were below the ELISA detection levels (Fig. 4(a),(b) ,(e)and(f)).
Effect of signaling inhibitors on M-CSF, GM-CSF, and G-CSF production
To investigate the IL-1 or TNF-signaling pathway involved in CSF production in synovial fibroblasts, we examined the effects of the MAPK family inhibitors, PD98059 (ERK1/2), SB203580 (p38), and SP600125 (JNK), and the NF B inhibitor, APDC. Synovial fibroblasts pretreated with these inhibitors for 15 min were stimulated with IL-1 or TNF-for 3 h or 8 h. GM-CSF production was inhibited by PD98059, SB203580, SP600125, and APDC in synovial fibroblasts stimulated with IL-1 for 3 h, whereas it was inhibited by PD98059, SB203580, and APDC in the cells stimulated with TNF-for 3 h (Fig. 5 (a) and (b) ). M-CSF and G-CSF protein levels at 3 h were below the detection limits of the ELISA kit(data not shown). However, M-CSF production could be detected by ELISA after 8 h treatment, and M-CSF production was inhibited by PD98059, SP600125, and APDC treatment in both IL-1 and TNF-8 hstimulated cells (Fig. 5(c)and(d) ). The effects of inhibitors on G-CSF could not be determined because the protein level of G-CSF after 8 h stimulation was again below the ELISA kit detection limit. We found that GM-CSF and M-CSF were ranked high in the list of genes that were upregulated in synovial fibroblasts by IL-1 and/or TNF-in microarray analysis (Table 3) The increase in M-CSF gene expression and protein production following IL-1 + TNF-co-stimulation for 8 h was less than that in GM-CSF and G-CSF. We also showed that M-CSF, but not GM-CSF or G-CSF, was expressed and produced in non-treated synovial fibroblasts (Figs. 2, 3 and   4 ). M-CSF is known to be constitutively and ubiquitously expressed, and data from Csf1op/Csf1op mice (which contain an inactivating mutation in the M-CSF gene)suggest that M-CSF is required for maintenance of certain tissue macrophage populations at the steady state (27) . In our 
